Literature DB >> 433766

Disopyramide-induced ventricular fibrillation.

W J Nicholson, C E Martin, J G Gracey, H R Knoch.   

Abstract

Three cases are described with documented ventricular fibrillation shortly after the patients received disopyramide in moderate dosage. Electrocardiograms showed markedly prolonged Q-T intervals in two patients and a prominent U wave with a prolonged Q-U interval in one patient, but no change in QRS width. Disopyramide-induced ventricular fibrillation appears to be similar to that caused by quinidine and is an indication to discontinue the drug.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 433766     DOI： 10.1016/0002-9149(79)90374-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.

Authors:  T J Campbell
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

Review 2.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

3.  Satalol-induced torsade de pointes.

Authors:  A Kontopoulos; A Filindris; F Manoudis; P Metaxas
Journal:  Postgrad Med J       Date:  1981-05       Impact factor: 2.401

4.  Successful management of serious disopyramide poisoning.

Authors:  D W Holt; M Helliwell; B O'Keeffe; A M Hayler; C B Marshall; G Cook
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

Review 5.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 6.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 7.  Torsades de pointes: prevention and therapy.

Authors:  A Keren; D Tzivoni
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

Review 8.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

9.  Torsades de pointes, a common arrhythmia, induced by medication.

Authors:  P T Ko; S Gulamhusein; W J Kostuk; G J Klein
Journal:  Can Med Assoc J       Date:  1982-09-01       Impact factor: 8.262

10.  Aggravation of ventricular arrhythmia. A drug-induced complication.

Authors:  P J Podrid
Journal:  Drugs       Date:  1985       Impact factor: 9.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.